VJHemOnc is committed to improving our service to you

ISA 2020 | AL amyloidosis during the pandemic

VJHemOnc is committed to improving our service to you

Efstathios Kastritis

Systemic light-chain (AL) amyloidosis is a multi-system disease and therefore can implicate a large variety of organ systems. COVID-19 is not only a systemic disease but may also cause cytokine storm and hence present a clinical threat to amyloidosis patients. Efstathios Kastritis, MD, University of Athens School of Medicine, Athens, Greece, outlines the challenges associated with the management of patients with AL amyloidosis during the COVID-19 pandemic. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter